Home
Portfolios
Favorites
Backtesting
Groups
Feed
N
PHARMA RESEARCH PRODUCTS Co., Ltd.
214450
Financials
🧐
Backtesting when deciding whether to buy or not
Backtest with dividend reinvestment included
Dividend
Dividend Per Share
Div Ratio
1.23%
Frequency
Financials
No Revenue data
Revenue
Operating Profit
Net Income
ROE
Debt Ratio
News
Posts
News
